4.6 Editorial Material

The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times

Related references

Note: Only part of the references are listed.
Article Cell Biology

Compromised steady-state germinal center activity with age in nonhuman primates

Kimberly Shankwitz et al.

AGING CELL (2020)

Article Immunology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Li Guo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Cell Biology

Immunoglobulin G glycosylation in aging and diseases

Ivan Gudelja et al.

CELLULAR IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

Taia T. Wang et al.

SCIENCE (2017)

Review Immunology

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Rudragouda Channappanavar et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Article Biochemistry & Molecular Biology

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Sheng-Fan Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)